Yumeng Wang

2 ta ish

Peking University

1. Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

   Changsong Qi, Chang Liu, Zhi Peng +31

   MaqolaOAOchiq kirish20252 iqtibos

   ABIABI:AkademIndex/2026.other.103004

2. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results

   Changsong Qi, Chang Liu, Jifang Gong +21

   Maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.431628